CorMedix (CRMD) Shares Outstanding (Diluted Average) (2014 - 2025)

CorMedix has disclosed Shares Outstanding (Diluted Average) across 7 years of filings, most recently posting $71.9 million for Q2 2025.

• Shares Outstanding (Diluted Average) for Q2 2025 came in at $71.9 million, up 24.94% year-over-year; the trailing twelve-month figure through Jun 2025 was $71.9 million (up 24.94% YoY), and the FY2024 annual result was $58.9 million, up 15.65% from the prior year.
• Shares Outstanding (Diluted Average) came in at $71.9 million for Q2 2025 at CorMedix, up from $69.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $71.9 million in Q2 2025 to a low of $37.5 million in Q3 2021.
• The 5-year median for Shares Outstanding (Diluted Average) is $45.4 million (2023), against an average of $49.0 million.
• Across the five-year window, Shares Outstanding (Diluted Average) grew 2.43% in 2022 and jumped 30.42% in 2024, its largest moves.
• CorMedix's Shares Outstanding (Diluted Average) stood at $37.7 million in 2021, then rose by 6.92% to $40.3 million in 2022, then gained by 26.39% to $50.9 million in 2023, then grew by 15.65% to $58.9 million in 2024, then advanced by 22.16% to $71.9 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $71.9 million (Q2 2025), $69.0 million (Q1 2025), and $58.9 million (Q4 2024), per Business Quant data.